Related Experiment Video
Updated: Jul 18, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetics in heart failure: where are we headed?
Rudolf A de Boer1, Maarten P van den Berg, Dirk J van Veldhuisen
1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. r.a.de.boer@thorax.umcg.nl
Congestive Heart Failure (Greenwich, Conn.)
|December 16, 2006
Summary
Genetic predisposition plays a role in heart failure, but understanding genetic variances and their impact, especially in noncoding DNA, remains incomplete. Future research aims to optimize heart failure treatment through genetic insights.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Genomics
Background:
- Heart failure is a complex condition with numerous contributing factors.
- Genetic predisposition to heart failure is an emerging area of research.
- Identified genetic defects and variances are linked to heart failure onset and progression.
Purpose of the Study:
- To highlight the incomplete understanding of the genetic basis of heart failure.
- To address the challenges in comprehending the functionality of genetic variances.
- To explore the difficulties in evaluating genetic variances in noncoding DNA.
Main Methods:
- Review of current research on genetic predisposition in heart failure.
- Discussion of challenges in whole-genome scanning and statistical analysis.
- Identification of knowledge gaps in functional genomics of heart failure.
Main Results:
- Current knowledge of heart failure genetics is limited by a lack of understanding of variance functionality.
- The impact of genetic variances in noncoding DNA on heart failure is largely unknown.
- Logistical and statistical hurdles impede comprehensive genetic analysis.
Conclusions:
- Further research is needed to elucidate the functional impact of genetic variances in heart failure.
- Overcoming challenges in genetic analysis will enable personalized treatment strategies.
- Future applications of genetic insights are expected to optimize heart failure management.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...